Clinical TrialsSearch results
Number of results: 553
Recruiting
- A study to investigate the efficacy and safety of dupilumab therapy compared with placebo in participants aged >=18 years with moderately to severely active ulcerative colitis with an eosinophilic phenotype
- Colitis ulcerative
- Tanaka Tomoyuki
- 2023-02-27
Recruiting
- Caplacizumab and immunosuppressive therapy without firstline therapeutic plasma exchange in adults with immune-mediated thrombotic thrombocytopenic purpura
- Thrombotic Thrombocytopenic Purpura
- Tanaka Tomoyuki
- 2023-04-16
Recruiting
- A research study to see how well new weekly medicine IcoSema, which is a combination of insulin icodec and semaglutide, controls blood sugar levels in people with type 2 diabetes, compared to daily insulin glargine(NN1535-4988:COMBINE 4)
- Type 2 diabetes
- takizaki Hiroshi
- 2024-01-26
Completed
- A research study to see how well the new weekly medicine IcoSema, which is a combination of insulin icodec and semaglutide, controls blood sugar level in people with type 2 diabetes compared to weekly insulin icodec (COMBINE1)
- type 2 diabetes
- Takizaki Hiroshi
- 2022-06-18
Not yet recruiting
- Clinical research on a neuroprotective effect of minocycline treatment in the acute stage of Ischemic Stroke
- Brain Infarction
- Takeshi Takahashi
- 2009-08-14
Not yet recruiting
- A study to test different doses of BI 1569912 in people with depression who take anti-depressive medicine
- Major depressive disorder
- Takekawa Shigeru
- 2024-04-16
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Thiazolidine
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to an Alpha-Glucosidase Inhibitor
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01